Evidence map›Paper›PMID 35006575›Full record

ArticleProbiotics and antimicrobial proteins2023

Optimization of Growth Conditions for the Production of Bacillus subtilis Using Central Composite Design and Its Antagonism Against Pathogenic Fungi.

Meyrem Vehapi, Benan İnan, Selma Kayacan-Cakmakoglu, Osman Sagdic, Didem Özçimen

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Agro Active Potential ofMicroorganisms · 2024
    Article
  6. Review
  7. Article
  8. Synthesis and characterization of titanium dioxide nanoparticles fromFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meyrem VehapiDepartment of Bioengineering, Yildiz Technical University, Istanbul, Turkey.ORCID 0000-0001-8235-3552
Benan İnanDepartment of Bioengineering, Yildiz Technical University, Istanbul, Turkey.
Selma Kayacan-CakmakogluDepartment of Food Engineering, Yildiz Technical University, Istanbul, Turkey.
Osman SagdicDepartment of Food Engineering, Yildiz Technical University, Istanbul, Turkey.
Didem ÖzçimenDepartment of Bioengineering, Yildiz Technical University, Istanbul, Turkey. ozcimen@yildiz.edu.tr.
Yıldız Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today, the enhancement of spore yields of Bacillus subtilis has considerable interest and has been widely investigated. In this context, studies have been carried out to improve the spore yield as well as the production amount. In order to perform this, optimization studies are conducted for large-scale production of B. subtilis in bioreactors. The prokaryotic structure, high extracellular production potential, lack of pathogenic activity, well-known fermentation technology and short fermentation time are the prominent advantages for the production of B. subtilis in a bioreactor. The Bacillus species produce a wide variety of antifungal and antimicrobial compounds, making them ideal biological control agents. In this study, first, the growth conditions of the medium were investigated and then optimized using the central composite design approach to achieve the highest productivity for the growth of B. subtilis. In the experiments, the effect of temperature of 25, 30 and 35 °C and pH level of 6.0, 7.0 and 8.0 on spore yield was studied. Moreover, the antifungal activity of the B. subtilis culture was investigated against pathogenic fungi: Colletotrichum gloeosporioides, Botrytis cinerea and Aspergillus brasiliensis.

Indexed as

Antifungal AgentsBacillus subtilisBioreactorsCulture MediaFermentationFungiAntifungal AgentsCulture MediaBacillus subtilisBioreactorFermentationOptimizationResponse surface methodology

Identifiers

PMID35006575
OpenAlexW4205999477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.